A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia.
Doherty JF, Pinder M, Tornieporth N, Carton C, Vigneron L, Milligan P, Ballou WR, Holland CA, Kester KE, Voss G, Momin P, Greenwood BM, McAdam KP, Cohen J.
Doherty JF, et al. Among authors: momin p.
Am J Trop Med Hyg. 1999 Dec;61(6):865-8. doi: 10.4269/ajtmh.1999.61.865.
Am J Trop Med Hyg. 1999.
PMID: 10674660
Clinical Trial.